📖 Approx. 3 minutes Updated: 2026.06.20
In this article, a medical industry-specialized M&A advisor explains from a practical perspective what issues arise when becoming a Special Medical Corporation in business succession and medical M&A involving confidentiality. We will provide specific countermeasures based on NDA, notification to staff, prevention of information leakage, tax incentives, and public interest requirements.
1. Industry Background of Becoming a Special Medical Corporation and Confidentiality
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including confidentiality, has become increasingly severe in recent years due to complex factors such as revisions to medical fees, rising personnel costs, and the burden of capital investment. Particularly from the perspective of NDA, notification to staff, and prevention of information leakage, interest in third-party succession M&A is growing.
At the same time, becoming a Special Medical Corporation is an important issue in medical M&A practice. By appropriately designing tax incentives and public interest requirements, a succession beneficial to both the transferor and transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the business flow, patient base, and equipment status specific to confidentiality, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical department. For confidential transfers, NDA, notification to staff, and prevention of information leakage are key to valuation.
- Design of Special Medical Corporation Status: Select the optimal scheme based on tax incentives and public interest requirements. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the medical department’s characteristics from a nationwide network. Carefully align desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm licenses, permits, and facility standards specific to confidentiality.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations for Confidentiality
In medical institution M&A involving confidentiality, NDA, notification to staff, and prevention of information leakage are key to successful succession. Numerous individual issues exist depending on the characteristics of the medical department, such as the continuity of the patient base, maintaining employment of staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic design based on market characteristics unique to confidentiality, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in supporting confidential successions, our company provides practical support from an industry-specific perspective.
4. Practical Details of Becoming a Special Medical Corporation
Becoming a Special Medical Corporation is an area requiring specialized consideration in medical M&A. Design based on tax incentives and public interest requirements is key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing mutually agreeable conditions for both transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for consultation?
A. It would be helpful if you could prepare financial statements for the past three fiscal years, patient trend data, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after an NDA is signed.
Q. What is the market price range for a confidential transfer?
A. For confidential transfers, NDA, notification to staff, and prevention of information leakage are key valuation factors. For clinics without beds, the guideline is 0.5 to 1.5 times annual revenue, and for hospitals with beds, 3 to 7 times EBITDA. We will provide more details in a free preliminary assessment.
Q. What are the points to note when proceeding with becoming a Special Medical Corporation?
A. Prior design based on tax incentives and public interest requirements is essential. Seamless execution of practical matters through expert collaboration is key to success.
Q. Will staff or patients know about the consultation?
A. Information will be disclosed on a limited basis after an NDA is signed, and no disclosure to related parties will be made before the final agreement. We ensure strict confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession | Medical M&A Practices from Successor Shortages to Success Stories
- Complete Guide to Clinic Sale and Transfer | Medical M&A Experts Explain Price Trends, Procedures, and Considerations
- How to Proceed with Medical M&A and Hospital Succession | Explaining the 6 Steps from Consultation to Agreement with Case Studies
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and CPAs
For Consultations on Becoming a Special Medical Corporation and Confidentiality, Contact M&A Medical
Strict Confidentiality · Free Initial Consultation · Success Fee Basis